#BrokerageRadar | Morgan Stanley on Dabur: Equal Weight with target price of ₹531. Delayed winter hits healthcare segment. @MorganStanley https://t.co/oa8JgUJw0e
#BrokerageRadar | CLSA on Dabur: Hold with target price of ₹582. Low single-digit revenue growth expected, resilient rural demand. Margins flat amid inflation pressures. @CLSAInsights https://t.co/kEjBsnf5TY
#Dabur India Q3 (YoY) Consolidated revenue is expected to register low single digit growth In India, home and personal care is expected to grow in mid to high single digit In India, healthcare is expected to be flattish due to delayed winter onset Beverages portfolio is…

Dabur India, a major player in the fast-moving consumer goods (FMCG) sector, is projected to experience low single-digit growth in consolidated revenue for the December quarter, according to recent updates. The company's performance is characterized by a stronger revenue growth in rural areas compared to urban regions. Specifically, the home and personal care segment is expected to see mid to high single-digit growth, while the healthcare segment may remain flat due to a delayed onset of winter. Additionally, the beverages portfolio's performance is under review. Analysts from CLSA and Morgan Stanley have provided insights, with CLSA maintaining a 'Hold' rating and a target price of ₹582, while Morgan Stanley has an 'Equal Weight' rating with a target price of ₹531, citing inflation pressures impacting margins.

